Company / Gross Profit
OptimizeRx Corp Gross Profit History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$59.4M
FY2025
5-year range
$24.1M / $59.4M
FY2021-FY2025
Trend
+38.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 9 consecutive years, from $4M in FY2016 to $59M in FY2025.
Based on SEC 10-K filings.
$59M in FY2025 with a 5-year CAGR of +30.9%.
Improved from $39M to $59M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +18.6%
- 5-Year CAGR
- +30.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- OptimizeRx Corp's gross profit has grown for 9 consecutive years.
- 5-year CAGR of +30.9%, indicating consistent growth.
- In FY2025, gross profit increased 38.4% year-over-year.
- Lowest gross profit in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $59.4M | +38.4% |
| FY2024 | $42.9M | +10.1% |
| FY2023 | $39.0M | +9.3% |
| FY2022 | $35.6M | +47.8% |
| FY2021 | $24.1M | +56.1% |
| FY2020 | $15.4M | +26.5% |
| FY2019 | $12.2M | +105.1% |
| FY2018 | $6.0M | +37.2% |
| FY2017 | $4.3M | +20.6% |
| FY2016 | $3.6M | +9.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026